In hopes of expediting the regulatory applications and processes for newly developed drugs, Perrigo (PRGO 0.70%) has created a position -- head of regulatory review -- and hired former Food and Drug Administration Director Keith Webber to fill the role, Perrigo announced yesterday.
Webber served in several positions with the FDA before joining Perrigo, including heading up the department that regulates prescription drugs, and as director of the FDA's generic-drug department, according to Perrigo's statement.
Commenting on Webber's appointment, Perrigo Chairman, President, and CEO Joseph Papa said, "He brings to us a wealth of strategic, scientific and regulatory experience from his years working with the FDA."
Speaking to Webber's role with Perrigo, Papa adde, "Keith will work closely with regulatory leadership to support new product selection and develop strategies and processes to achieve high quality applications and timely approvals, enabling us to bring quality, affordable products to the market."
Webber's appointment as head of regulatory review becomes effective Oct. 21, according to Perrigo.
